Sagimet Biosciences Inc. (SGMT) Presents at Oppenheimer 36th Annual Healthcare Life Sciences Conference Transcript [Seeking Alpha]
Sagimet Biosciences Inc. - Series A (SGMT)
Company Research
Source: Seeking Alpha
David Happel - CEO, President & Director Eduardo Martins - Chief Medical Officer Robert D'Urso - Senior Vice President of New Products Thierry Chauche - CFO & Principal Accounting Officer Conference Call Participants Jay Olson - Oppenheimer & Co. Inc., Research Division Presentation Jay Olson Oppenheimer & Co. Inc., Research Division Welcome to Oppenheimer's 36th Annual Life Science Conference. I'm Jay Olson, one of the biotech analysts here at Oppenheimer. And it's a pleasure to welcome you to our discussion with Sagimet Biosciences. And it's an honor to introduce Dave Happel, the CEO of Sagimet; Rob D'Urso, SVP of New Products; Eduardo, Chief Medical Officer; and Thierry, the Chief Financial Officer. Thanks so much guys for bringing your team here today and making time for us. David Happel CEO, President & Director Thanks, Jay. Thanks for the invitation. Great to be here. Jay Olson Oppenheimer & Co. Inc., Research Division It's our pleasure, and we're
Show less
Read more
Impact Snapshot
Event Time:
SGMT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SGMT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SGMT alerts
High impacting Sagimet Biosciences Inc. - Series A news events
Weekly update
A roundup of the hottest topics
SGMT
News
- Sagimet Biosciences Highlights Denifanstat MASH Data, Combo Plans at Oppenheimer Healthcare Conf. [Yahoo! Finance]Yahoo! Finance
- Sagimet Biosciences Announces Participation in Three Upcoming Investor Conferences [Yahoo! Finance]Yahoo! Finance
- Sagimet Biosciences Announces Participation in Three Upcoming Investor ConferencesGlobeNewswire
- Sagimet Biosciences Announces Participation in Two Upcoming Investor ConferencesGlobeNewswire
- Sagimet Biosciences (NASDAQ:SGMT) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $29.00 price target on the stock.MarketBeat
SGMT
Earnings
- 11/13/25 - Beat
SGMT
Sec Filings
- 2/20/26 - Form 4
- 2/20/26 - Form 4
- 2/20/26 - Form 4
- SGMT's page on the SEC website